Marie-Angèle de Looze
Institut national de la recherche agronomique
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Marie-Angèle de Looze.
Scientometrics | 1997
Marie-Angèle de Looze; Juliette Lemarié
Different corpuses are analysed by means of co-word analysis, in the framework of technological watch of the industrial valorization of plant proteins. The comparison of keyword clusters reveals unequal results, raising the question of the relevance of information retrieval. The corpuses compiled do not provide all the important signals that can be expected from this type of study. Research on several data bases (five) provides increasingly detailed images which allow for rapid progress, with the experts, towards critical points of information.
Scientometrics | 2002
Shyama V. Ramani; Marie-Angèle de Looze
In order to formulate firm, national or regional technology policy, it is necessary to have indicators that can measure technological competence. This paper develops a set of indicators using patent statistics to compare the “knowledge base” of individuals, laboratories, firms or nations. These indicators are then applied to the patent applications in France, Germany and the U.K. in the biotechnology sectors. The paper shows that France is lagging behind Germany and the U.K. in technology stocks (or its patent applications) in all biotechnology fields. However it is the leader in the technology network supporting the foods industry. It has a comparative advantage in terms of either technology stock counts or networks in Genetic Engineering, Pharmaceuticals, Foods, Chemicals, Cell Culture and Biocatalysis. Germany is leading in many sectors, but in all sectors in which it is a leader, it is a specialized leader, i.e. its technology networks need to be more extensive. It has a comparative advantage in terms of either technology stock counts or networks in all sectors except Genetic Engineering, Pharmaceuticals, Agriculture and Cell Culture. The U.K. is the leader in the important field of Genetic Engineering and in terms of the entire technology networks in the biotechnology sectors. It has a comparative advantage in terms of either technology stock counts or networks in Genetic Engineering, Pharmaceuticals, Agriculture and Purification.
Nature Biotechnology | 2003
Roger Coronini; Marie-Angèle de Looze; Pierre Puget; Gérard Bley; Shyama V. Ramani
A survey of the scientific and patent literature on single-nucleotide variants reveals the dominance of research centers in the United States and the prolific patenting of SNP technology by a select group of biotechnology companies.
Scientometrics | 2000
Stéphane Lemarié; Marie-Angèle de Looze; Vincent Mangematin
Both the technological and market focus of 228 European biotechnology SMEs are analysed in this paper. Data from the Genetic Engineering catalogue provide a complementary representation compared to the patent publications that are most commonly used. Results of the analysis produce a new view of the development of biotech SMEs. First, no pattern of specialisation by country is observed, even though three types of company with different technological focus can be distinguished in the sample. Second, it is argued that the rapid technological evolution in this domain can hardly be explained by a rapid evolution of the technological basis of the companies, and should consequently be explained primarily by the creation of new SMEs. Third, four different patterns of linkage between technology and market focus are observed, by means of co-word analysis.
Economics of Innovation and New Technology | 2005
Pier Paolo Saviotti; Marie-Angèle de Looze; M. A. Maupertuis
In this article, a method to map the knowledge base (KB) of firms is developed and applied to the study of strategic changes, mergers and acquisitions. The empirical data are related to three firms, Hoechst, Rhône-Poulenc and Aventis, which resulted from the merger of the first two. Our study shows how the KB of both Hoechst and Rhône-Poulenc changed gradually reflecting their strategic reorientation away from chemistry and towards the life sciences. While the previous transition produced a segmented KB with the chemistry and biology subsets largely separated, the merger led a more closely integrated KB. The KB of some Aventis subsidiaries have been studied as well.
Scientometrics | 2000
Shyama V. Ramani; Marie-Angèle de Looze
In a recent article a set of indicators have been proposed drawing upon patent statistics, which are meant to describe and compare firm and national research competence. However this article has raised more questions on the validity of such indicators as well as on their use. We have thus examined these issues so as to clarify the nature of the problems involved in the construction of competence and competitive indicators of firms and nations and their subsequent implementation on data bases.
Scientometrics | 1994
Marie-Angèle de Looze
The application of biliometric methods and tools for analysing data from information sciences and patent data bases allow us to obtain different representations of an area that is particularly fragmented and difficult to interpret: plant biotechnologies in which nitrogen fixation has been particularly highlighted.
Research Policy | 1996
Pierre-Benoit Joly; Marie-Angèle de Looze
Technology Analysis & Strategic Management | 2002
Shyama V. Ramani; Marie-Angèle de Looze
International Journal of Biotechnology | 2001
Marie-Angèle de Looze; Roger Coronini; Pierre-Benoit Joly